Transdermal Nanogel Therapy in the Management of Skin Cancer. Cet article n’est pas disponible.
Langue : anglais
Edité par LAP LAMBERT Academic Publishing, 2019
- Livre broché
- Neuf

Vendeur : preigu, Osnabrück, Allemagnepreigu
Vendeur avec une évaluation de 5 étoiles
Vendeur AbeBooks depuis 5 août 2024
Indisponible
Livre broché
Etat: Neuf
EUR 61,30
A propos de cet article
Transdermal Nanogel Therapy in the Management of Skin Cancer | Prashant Sahu (u. a.) | Taschenbuch | 176 S. | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786200211170 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
N° de réf. du vendeur 117025641
- Titre
- Transdermal Nanogel Therapy in the Management of Skin Cancer
- Auteur
- Prashant Sahu (u. a.)
- Éditeur
- LAP LAMBERT Academic Publishing
- Année de publication
- 2019
- État de l'article
- Neu
- Reliure
- Taschenbuch
- Langue
- anglais
- ISBN à 10 chiffres
- 6200211175
- ISBN à 13 chiffres
- 9786200211170
- Poids de l'article
- 280 grammes
- Dimensions
- 220 x 150 x 12 mm
- Catalogues du vendeur
- Bücher
The concept of this book is focused on transdermal Nanogel therapy against skin cancer. Skin cancer is the type of cancer which arises from skin, invades other part of the body and one of the most common types of cancer with increasing number of cases worldwide. From last few decades the advancement of transdermal drug delivery system is on the peak and when the disease needle pointed towards cancer especially skin cancer, transdermal delivery systems emerged as the first choice of treatment by virtue of patient compliance. Nanogels are the nano-sized system of their parent hydro gels, establishing high water uptake ability, swelling capability, degradability, pH-sensitivity and shows promising role in controlled delivery of therapeutics, delivery of cell, wound healing and tissue engineering. The prime objective of this silhouette was to investigate the anticancer potential of transdermal nanogel consisting anticancer drug against melanoma. The book highlights the enhanced onsite targeting potential of nanogel encapsulating anticancer drug offering offers patient compliance, decreasing dose frequency and opening novel avenue against treatment of skin cancer in clinical platform.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.